PIC1 Injection Therapy for Relapsed/Refractory B-NHL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PIC1 Injection Therapy for Relapsed/Refractory B-NHL	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma	Recruiting	Phase 1	2026-03-06		NCT07456371

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing Precision Biotech Co., Ltd	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	71

Clinical trials